Clinical Trials

30 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT05143619 2026-04-15

Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines

100 enrolled

Carcinoma, Hepatocellular

NCT05394259 2026-04-15

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Phase 1 Recruiting

36 enrolled

BreastGastrointestinal

Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06426992 2026-04-13

Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies

128 enrolled

Carcinoma, Hepatocellular

NCT06938945 2026-04-13

Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial

500 enrolled

Carcinoma, Hepatocellular

NCT06944483 2026-04-09

ISTAR-01

138 enrolled

Carcinoma, Hepatocellular

NCT06979219 2026-04-09

ISTAR-02

146 enrolled

Carcinoma, Hepatocellular

NCT07166406 2026-04-08

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Phase 3 Recruiting

226 enrolled

Carcinoma, Hepatocellular

NCT06342414 2026-04-03

ELUCIDATE

400 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

NCT06553885 2026-04-01

Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT07062055 2026-04-01

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

54 enrolled

Carcinoma, Hepatocellular

NCT07312292 2026-03-30

RADIANT

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT04390724 2026-03-27

Optimizing Y90 Therapy for Radiation Lobectomy

104 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT06902246 2026-03-27

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

30 enrolled

Carcinoma, Hepatocellular

NCT07331883 2026-03-27

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

35 enrolled

Carcinoma, Hepatocellular

NCT07495215 2026-03-27

A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection

20 enrolled

Carcinoma, Hepatocellular

NCT07059494 2026-03-23

Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant

Phase 4 Recruiting

Carcinoma, Hepatocellular

NCT05128890 2026-03-20

Evaluation of Resection Techniques for Pancreatic Tumors

431 enrolled

Carcinoma, Hepatocellular, Pancreatic Neoplasms

NCT06345508 2026-03-20

QUS in HCC

328 enrolled

Disease, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05629845 2026-03-19

EUS-SPV

84 enrolled

Carcinoma, Hepatocellular

NCT07351669 2026-03-19

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

250 enrolled

Carcinoma, Hepatocellular

NCT06077591 2026-03-18

PDO

Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT06621472 2026-03-18

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

90 enrolled

Carcinoma, Hepatocellular

NCT07010497 2026-03-18

IAPETUS

33 enrolled

Carcinoma, Hepatocellular

NCT05468359 2026-03-16

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

64 enrolled

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT05528952 2026-03-16

TERTIO

105 enrolled

Carcinoma, Hepatocellular

NCT06796114 2026-03-16

PREDICT-HCC

120 enrolled

Carcinoma, Hepatocellular

NCT05901519 2026-03-13

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

20 enrolled

Carcinoma, Hepatocellular

NCT07469319 2026-03-13

BISHOP

617 enrolled

Fibrosis, Carcinoma, Hepatocellular

NCT05095714 2026-03-12

FASTRAK

944 enrolled

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05269381 2026-03-12

PNeoVCA

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Carcinoma, Merkel Cell, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

324 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06537193 2026-03-10

Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment

455 enrolled

Carcinoma, Hepatocellular

NCT02379377 2026-03-09

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Phase 1 Recruiting

110 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04792463 2026-03-09

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

500 enrolled

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Mesothelioma, Cholangiocarcinoma

NCT04380545 2026-03-06

Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

Carcinoma, Hepatocellular

NCT06885879 2026-03-04

Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT06218420 2026-03-03

TRANSRAD-01

139 enrolled

Carcinoma, Hepatocellular

NCT07295275 2026-03-03

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

200 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07445412 2026-03-03

I-GROWtoh

2,000 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

NCT06789848 2026-02-27

Ligufalimab and Cadonilimab in Advanced Liver Cancers

64 enrolled

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT07432347 2026-02-27

DELIVER

270 enrolled

Carcinoma, Hepatocellular

NCT07436845 2026-02-27

Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy

90 enrolled

Carcinoma, Hepatocellular

NCT03942328 2026-02-24

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

85 enrolled

Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT04134559 2026-02-24

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

18 enrolled

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT05497531 2026-02-24

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Carcinoma, Hepatocellular, Pancreatic Neoplasms, Cholangiocarcinoma

NCT07429864 2026-02-24

Bio-Delta

20 enrolled

Communicable Diseases, Carcinoma, Hepatocellular, Liver Cirrhosis, HIV Infections, Dysbiosis

NCT07428356 2026-02-23

HALT

Carcinoma, Hepatocellular

NCT05488522 2026-02-20

SBRT With Atezo/Bev for HCC

Phase 1 Recruiting

18 enrolled